{"id":"https://openalex.org/W2170406807","doi":"https://doi.org/10.3111/13696990903269673","title":"Cost impact of oral capecitabine compared to intravenous taxane-based chemotherapy in first-line metastatic breast cancer","display_name":"Cost impact of oral capecitabine compared to intravenous taxane-based chemotherapy in first-line metastatic breast cancer","publication_year":2009,"publication_date":"2009-01-01","ids":{"openalex":"https://openalex.org/W2170406807","doi":"https://doi.org/10.3111/13696990903269673","mag":"2170406807","pmid":"https://pubmed.ncbi.nlm.nih.gov/19732030"},"language":"en","primary_location":{"id":"doi:10.3111/13696990903269673","doi":"https://doi.org/10.3111/13696990903269673","is_oa":false,"landing_page_url":"https://doi.org/10.3111/13696990903269673","pdf_url":null,"source":{"id":"https://openalex.org/S155267287","display_name":"Journal of Medical Economics","issn_l":"1369-6998","issn":["1369-6998","1941-837X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-c","anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320449","host_organization_name":"Informa","host_organization_lineage":["https://openalex.org/P4310320449"],"host_organization_lineage_names":["Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medical Economics","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5046182172","display_name":"FABIAN T. CAMACHO","orcid":"https://orcid.org/0000-0002-4878-0283","observed_orcids":["https://orcid.org/0000-0002-4878-0283"]},"institutions":[{"id":"https://openalex.org/I130769515","display_name":"Pennsylvania State University","ror":"https://ror.org/04p491231","country_code":"US","type":"education","lineage":["https://openalex.org/I130769515"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Fabian T. Camacho","raw_affiliation_strings":["Department of Health Evaluation Sciences, Pennsylvania State University College of Medicine, Hershey, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Health Evaluation Sciences, Pennsylvania State University College of Medicine, Hershey, PA, USA","institution_ids":["https://openalex.org/I130769515"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001429047","display_name":"Jun Wu","orcid":"https://orcid.org/0000-0003-2515-6418","observed_orcids":["https://orcid.org/0000-0003-2515-6418"]},"institutions":[{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jun Wu","raw_affiliation_strings":["Department of Pharmacy Practice and Administration, The Ohio State University College of Pharmacy, Columbus, OH, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy Practice and Administration, The Ohio State University College of Pharmacy, Columbus, OH, USA","institution_ids":["https://openalex.org/I52357470"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101554004","display_name":"Wenhui Wei","orcid":"https://orcid.org/0000-0002-8766-7769","observed_orcids":["https://orcid.org/0000-0002-8766-7769"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Wenhui Wei","raw_affiliation_strings":["Formerly at: Roche Pharmaceuticals, Nutley, NJ, USA; current address: Schering-Plough Pharmaceuticals, Kenilworth, NJ, USA","Formerly at: Roche Pharmaceuticals, Nutley, NJ, USA","current address: Schering-Plough Pharmaceuticals, Kenilworth, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Formerly at: Roche Pharmaceuticals, Nutley, NJ, USA; current address: Schering-Plough Pharmaceuticals, Kenilworth, NJ, USA","institution_ids":[]},{"raw_affiliation_string":"Formerly at: Roche Pharmaceuticals, Nutley, NJ, USA","institution_ids":[]},{"raw_affiliation_string":"current address: Schering-Plough Pharmaceuticals, Kenilworth, NJ, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059225709","display_name":"Gretchen Genevieve Kimmick","orcid":"https://orcid.org/0000-0001-7096-9624","observed_orcids":["https://orcid.org/0000-0001-7096-9624"]},"institutions":[{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gretchen Kimmick","raw_affiliation_strings":["Department of Clinical Oncology, Duke University Medical Center, Durham, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Oncology, Duke University Medical Center, Durham, NC, USA","institution_ids":["https://openalex.org/I4210126298"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019453350","display_name":"Roger T. Anderson","orcid":"https://orcid.org/0000-0001-8112-4117","observed_orcids":["https://orcid.org/0000-0001-8112-4117"]},"institutions":[{"id":"https://openalex.org/I130769515","display_name":"Pennsylvania State University","ror":"https://ror.org/04p491231","country_code":"US","type":"education","lineage":["https://openalex.org/I130769515"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Roger T. Anderson","raw_affiliation_strings":["Department of Health Evaluation Sciences, Pennsylvania State University College of Medicine, Hershey, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Health Evaluation Sciences, Pennsylvania State University College of Medicine, Hershey, PA, USA","institution_ids":["https://openalex.org/I130769515"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5015605411","display_name":"Rajesh Balkrishnan","orcid":"https://orcid.org/0000-0001-9363-9257","observed_orcids":["https://orcid.org/0000-0001-9363-9257"]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Rajesh Balkrishnan","raw_affiliation_strings":["University of Michigan Schools of Pharmacy and Public Health, Ann Arbor, MI, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Michigan Schools of Pharmacy and Public Health, Ann Arbor, MI, USA","institution_ids":["https://openalex.org/I27837315"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5015605411"],"corresponding_institution_ids":["https://openalex.org/I27837315"],"apc_list":null,"apc_paid":null,"fwci":2.2382,"has_fulltext":false,"cited_by_count":7,"citation_normalized_percentile":{"value":0.91839709,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":96},"biblio":{"volume":"12","issue":"3","first_page":"238","last_page":"245"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12708","display_name":"Economic and Financial Impacts of Cancer","score":0.9458000063896179,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T12708","display_name":"Economic and Financial Impacts of Cancer","score":0.9458000063896179,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.03229999914765358,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.01269999984651804,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/capecitabine","display_name":"capecitabine","score":0.9210000038146973},{"id":"https://openalex.org/keywords/taxanes","display_name":"taxanes","score":0.8610000014305115},{"id":"https://openalex.org/keywords/metastatic-breast-cancer","display_name":"metastatic breast cancer","score":0.9649999737739563},{"id":"https://openalex.org/keywords/first-line-chemotherapy","display_name":"first-line chemotherapy","score":0.9959999918937683},{"id":"https://openalex.org/keywords/health-care-costs","display_name":"health care costs","score":0.9570000171661377},{"id":"https://openalex.org/keywords/oral-chemotherapy","display_name":"oral chemotherapy","score":0.5870000123977661},{"id":"https://openalex.org/keywords/intravenous-chemotherapy","display_name":"intravenous chemotherapy","score":0.8809999823570251},{"id":"https://openalex.org/keywords/health-care-utilization","display_name":"health care utilization","score":0.8650000095367432},{"id":"https://openalex.org/keywords/medicaid","display_name":"Medicaid","score":0.5479999780654907},{"id":"https://openalex.org/keywords/medicare","display_name":"Medicare","score":0.6779999732971191},{"id":"https://openalex.org/keywords/cost-comparison","display_name":"cost comparison","score":0.4269999861717224}],"concepts":[{"id":"https://openalex.org/C2777909004","wikidata":"https://www.wikidata.org/wiki/Q420207","display_name":"Capecitabine","level":4,"score":0.9646860361099243},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8924332857131958},{"id":"https://openalex.org/C2777511904","wikidata":"https://www.wikidata.org/wiki/Q425227","display_name":"Taxane","level":4,"score":0.7814674377441406},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.6341115236282349},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6219419240951538},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.527525007724762},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.5155982375144958},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.47506946325302124},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.4287338852882385},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3919951617717743},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3363295793533325},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.06928855180740356},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000069287","descriptor_name":"Capecitabine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000964","descriptor_name":"Antimetabolites, Antineoplastic","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000964","descriptor_name":"Antimetabolites, Antineoplastic","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007262","descriptor_name":"Infusions, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016014","descriptor_name":"Linear Models","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016527","descriptor_name":"Drug Costs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018426","descriptor_name":"SEER Program","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D043823","descriptor_name":"Taxoids","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D043823","descriptor_name":"Taxoids","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.3111/13696990903269673","doi":"https://doi.org/10.3111/13696990903269673","is_oa":false,"landing_page_url":"https://doi.org/10.3111/13696990903269673","pdf_url":null,"source":{"id":"https://openalex.org/S155267287","display_name":"Journal of Medical Economics","issn_l":"1369-6998","issn":["1369-6998","1941-837X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-c","anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320449","host_organization_name":"Informa","host_organization_lineage":["https://openalex.org/P4310320449"],"host_organization_lineage_names":["Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medical Economics","raw_type":"journal-article"},{"id":"pmid:19732030","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19732030","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of medical economics","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[{"id":"https://openalex.org/G5039385237","display_name":null,"funder_award_id":"R01CA12137","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":23,"referenced_works":["https://openalex.org/W1522433939","https://openalex.org/W1981254120","https://openalex.org/W1990887842","https://openalex.org/W2004853608","https://openalex.org/W2007359949","https://openalex.org/W2031428574","https://openalex.org/W2039310969","https://openalex.org/W2066059923","https://openalex.org/W2087675944","https://openalex.org/W2092610057","https://openalex.org/W2098169322","https://openalex.org/W2099658604","https://openalex.org/W2130082354","https://openalex.org/W2143399650","https://openalex.org/W2153589240","https://openalex.org/W2155278710","https://openalex.org/W2165782026","https://openalex.org/W2243799954","https://openalex.org/W2339746046","https://openalex.org/W2436631134","https://openalex.org/W2590769995","https://openalex.org/W2604892020","https://openalex.org/W2608997859"],"related_works":["https://openalex.org/W2035437286","https://openalex.org/W2589453077","https://openalex.org/W2123082307","https://openalex.org/W2997001651","https://openalex.org/W2033623035","https://openalex.org/W2069911708","https://openalex.org/W2166839079","https://openalex.org/W2034044828","https://openalex.org/W2050146444","https://openalex.org/W2042143453"],"abstract_inverted_index":{"OBJECTIVE:":[0],"Few":[1],"studies":[2],"have":[3],"examined":[4,119],"the":[5,23,137,150,153,206,218],"costs":[6,93,135,164,215,239],"associated":[7,163,210],"with":[8,15,32,67,87,200,211],"differing":[9],"first-line":[10,30,39,85,232],"chemotherapy":[11,31,40,86,184],"regimens":[12],"in":[13,136,149,183],"patients":[14,82,128,141,154,167,195],"metastatic":[16],"breast":[17],"cancer":[18],"(MBC).":[19],"This":[20],"study":[21],"compares":[22],"relative":[24],"cost":[25,109],"impact":[26,110],"of":[27,111,115],"women":[28,227,242],"starting":[29,129,142,243],"capecitabine":[33,88,112,143,169,207,230],"versus":[34,89],"taxanes.":[35,90],"METHODS:":[36],"Women":[37],"receiving":[38],"for":[41,94,194,234],"MBC":[42,235],"from":[43,49],"1998":[44],"to":[45,65,77,166,180,191,217,241],"2002":[46],"were":[47,62,75,99,177],"identified":[48],"a":[50,121],"hybrid":[51],"North":[52],"Carolina":[53],"Medicaid-claims-tumour":[54],"registry":[55],"linked":[56],"database":[57],"and":[58,61,72,162,187,203],"Medicare":[59],"records,":[60],"followed":[63],"through":[64],"2005":[66],"claims":[68,186],"data.":[69],"Statistical":[70],"t-":[71],"chi-square":[73],"tests":[74],"used":[76],"compare":[78],"baseline":[79],"characteristics":[80],"between":[81],"who":[83,228],"received":[84,229],"Projected":[91],"mean":[92],"12":[95],"months":[96],"continuous":[97],"eligibility":[98],"estimated":[100],"using":[101,120],"an":[102],"ordinary":[103],"least":[104],"squares":[105],"linear":[106],"regression.":[107],"Overall":[108],"after":[113],"start":[114],"therapy":[116],"was":[117,209],"then":[118],"multivariate":[122],"log-linear":[123],"regression":[124],"model.":[125],"RESULTS:":[126],"While":[127],"taxanes":[130,156],"had":[131,236],"significantly":[132,158,237],"lower":[133,181,213,238],"total":[134],"pre-index":[138],"year":[139],"than":[140],"(mean:":[144,170],"$20,042":[145],"vs.":[146,172],"$35,538,":[147],"p<0.001),":[148],"post-index":[151],"year,":[152],"on":[155,168,196],"experienced":[157],"higher":[159],"healthcare":[160,214],"utilisation":[161],"compared":[165,216,240],"$43,353":[171],"$35,842,":[173],"p=0.0089).":[174],"The":[175],"differences":[176],"primarily":[178],"attributable":[179],"expenses":[182],"related":[185],"fewer":[188],"visit":[189],"days":[190],"outpatient":[192],"settings":[193],"capecitabine.":[197],"After":[198],"adjustment":[199],"propensity":[201],"scores":[202],"other":[204],"confounders,":[205],"group":[208,220],"32%":[212],"taxane":[219,244],"(p=0.0001).":[221],"CONCLUSIONS:":[222],"In":[223],"this":[224],"population-based":[225],"study,":[226],"as":[231],"treatment":[233],"therapy.":[245]},"counts_by_year":[{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}